Forbion Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
Photo of Philip Astley-Sparke, Venture Partner at Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Boston (MA)
Photo of Juliette Audet, Partner at Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Netherlands
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
Photo of Marco Boorsma, General Partner at Forbion
Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Naarden (Netherlands), Investors in Amsterdam (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)
+3
Photo of Jasper Bos, General Partner at Forbion
Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Amsterdam (Netherlands)
n/a
$1.5M
($100K - $5.0M)
Investors in Amsterdam (Netherlands)
Photo of Audrey Cacaly, Senior Associate at Forbion
Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Netherlands
n/a
$1.5M
($100K - $5.0M)
Investors in Munich (Germany)
Photo of Wouter Joustra, General Partner at Forbion
Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Amsterdam (Netherlands)
Investors in BioTech (Series B)
Photo of Dirk Kersten, General Partner at Forbion
Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Amsterdam (Netherlands)
Photo of Nanna Luneborg, General Partner at Forbion
Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Denmark
Photo of Geert-Jan Mulder, Managing Partner at Forbion
Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Naarden (Netherlands)
Photo of Holger Reithinger, General Partner at Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Munich (Germany)
n/a
$1.5M
($100K - $5.0M)
Investors in Amsterdam (Netherlands)
Photo of Patrick Round, Venture Partner at Forbion
Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Cambridge (United Kingdom)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
Photo of Sander Slootweg, Managing Partner at Forbion
Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Netherlands
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
+2
n/a
$1.5M
($100K - $5.0M)
Investors in Amsterdam (Netherlands)
Investors in BioTech (Seed), Investors in BioTech (Series A)
Photo of Martien van Osch, Managing Partner at Forbion
Forbion
n/a
$1.5M
($100K - $5.0M)
Investors in Amsterdam (Netherlands)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
+2